Statistics

Total Visits

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study82

Select a period of time:

Number of views in the range

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study18

Views

Views
September 20256
October 20250
November 20255
December 20254
January 20263
February 20260
March 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
United Kingdom4
Brazil2
Finland2
Argentina2
Netherlands1
 

Top cities views

Views
Helsinki2
Amsterdam1
Dallas1
Edinburgh1
Guarujá1
Necochea1
Villa Krause1